See also this year's filing and all EDGAR filings for this company.
PDF Report 0001586105_2016_Zyla_Life_Sciences.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'} |
Graph
Absolute values for 0001586105, Zyla Life Sciences
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 150,238,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 10,380,000 |
| 2 | PropertyPlantAndEquipmentNet | 7,801,000 |
| 3 | remainder_Assets | 3,997,000 |
| 4 | LiabilitiesCurrent | 28,664,000 |
| 5 | LiabilitiesNoncurrent | 52,790,000 |
| 6 | remainder_Liabilities | 1,740,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 26,474,000 |
| 9 | ResearchAndDevelopmentExpense | 27,054,000 |
| 10 | remainder_Expenses | 20,800,000 |
| 11 | remainder_Revenues | 22,830,000 |
| 12 | remainder_NetIncome | -6,435,000 |
| 13 | remainder_ComprehensiveNetIncome | 130,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 172,416,000 |
| 1 | Liabilities | 83,194,000 |
| 2 | Expenses | 74,328,000 |
| 3 | Revenues | 22,830,000 |
| 4 | StockholdersEquity | 89,222,000 |
| 5 | NetIncome | -57,933,000 |
| 6 | ComprehensiveNetIncome | -57,868,000 |
| 7 | BaseVar | 179,666,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.07 |
| 9 | EconomicCapitalRatio | 2.36 |
Edgar->Model Mapping
Feature Distribution
Change over Time
